Quarterly Results

SOCRUS BIO SCIENCES LTD.

NSE : NABSE : 524719ISIN CODE : INE858A01039Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.480 (0 %)
PREV CLOSE ( ) 0.48
OPEN PRICE ( ) 0.49
BID PRICE (QTY) 0.48 (600)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 300
TODAY'S LOW / HIGH ( )0.48 0.49
52 WK LOW / HIGH ( ) 0.480.49
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2014
Sep 2014
Jun 2014
Mar 2014
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
2.42
2.51
4.3
2.5
Total Expenditure
2.34
2.46
4.38
3.7
PBIDT (Excl OI)
0.08
0.04
-0.08
-1.2
Other Income
NA
NA
0.00
NA
Operating Profit
0.08
0.05
-0.08
-1.2
Interest
NA
NA
0.00
NA
Exceptional Items
NA
NA
NA
NA
PBDT
0.08
0.05
-0.08
-1.2
Depreciation
NA
NA
NA
NA
Profit Before Tax
0.08
0.05
-0.08
-1.2
Tax
NA
NA
0.00
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
0.08
0.05
-0.08
-1.2
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
0.08
0.05
-0.08
-1.2
Equity Capital
320
320
320
320
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
0.00
0.00
-0.00
-0.03
Calculated EPS (Annualised)
0.01
0.00
-0.01
-0.15
No of Public Share Holdings
20643240
20643240
20643240
20643240
% of Public Share Holdings
64.5
64.5
64.5
64.5
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
3.30
1.99
-1.86
-48
PBIDTM%
3.30
1.99
-1.86
-48
PBDTM%
3.30
1.99
-1.86
-48
PBTM%
3.30
1.99
-1.86
-48
PATM%
3.30
1.99
-1.86
-48
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.